1Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA. pez2001@med.cornell.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers engineered the ubiquitin-proteasome pathway for targeted protein degradation. This novel approach offers precise control over protein function and potential therapeutic applications for human diseases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: